Hib cases rise during vaccine shortage

Minnesota health officials are drawing a link between the shortage of Merck's Hib childhood vaccine and an increase in that disease, which can cause meningitis and pneumonia. They are reporting five cases of Hib, including one death, for 2008; that's the highest level since the early 1990s, when Hib vaccination grew widespread. Report

Suggested Articles

GSK's Shingrix supply has recovered after COVID-19 prompted a slowdown in vaccinations.

To eradicate SARS-CoV-2, we'll need a vaccine that's 70% effective—and 70% of the population will need to receive it, an FDA official says.

The U.K. government, fearing losing the supply race, agreed to buy 60 million doses of GSK-Sanofi's COVID-19 vaccine even before phase 1.